A comparative study of the effects of concentrated growth factors in two different forms on osteogenesis in vitro

Wang,Liping; Wan,Mianjia; Li,Zhengmao; Zhong,Ningying; Liang,Dongliang; Ge,Linhu

doi:10.3892/mmr.2019.10313

A comparative study of the effects of concentrated growth factors in two different forms on osteogenesis in vitro

Authors:
- Liping Wang
- Mianjia Wan
- Zhengmao Li
- Ningying Zhong
- Dongliang Liang
- Linhu Ge
View Affiliations

Affiliations: Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, P.R. China
Published online on: May 30, 2019 https://doi.org/10.3892/mmr.2019.10313
Pages: 1039-1048
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Extending the release cycle of growth factors to match the cycle of bone remodeling is difficult. When using concentrated growth factors (CGFs), the release of growth factors is excessively rapid. In the present study, CGF samples were prepared by centrifugation. CGF samples were then lyophilized and grinded into a powder, which was termed freeze‑dried CGF. The freeze‑dried CGF samples were mixed with chitosan‑alginate composite hydrogels, and the mixture was lyophilized. The result was a chitosan‑alginate composite CGF membrane, which was called sustained‑release CGF. This study investigated whether freeze‑dried CGF in a chitosan‑alginate composite gel can release CGF steadily to achieve effective osteogenesis. The proliferation and osteogenic expression of MC3T3‑E1 cells induced by the supernatants from incubation with freeze‑dried CGF and sustained‑release CGF were evaluated. The concentrations of the growth factors, transforming growth factor β1 (TGF‑β1), insulin‑like growth factor‑1 (IGF‑1), platelet‑derived growth factor‑AB (PDGF‑AB) and vascular endothelial growth factor (VEGF), in these two experimental groups at different times were determined by ELISA kits. The freeze‑dried CGF showed better osteogenic performance than the sustained‑release CGF in the early stages. At later stages, the sustained‑release CGF had significant advantages over freeze‑dried CGF in terms of promoting osteogenic mineralization. By characterizing the biologic properties of the CGF in the two different forms in vitro, we obtained a better understanding of their clinical effects.

View Figures

View References

1	Whitman DH, Berry RL and Green DM: Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 55:1294–1299. 1997. View Article : Google Scholar : PubMed/NCBI
2	de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H and Tol JL: Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA. 303:144–149. 2010. View Article : Google Scholar : PubMed/NCBI
3	Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJJ, Mouhyi J and Gogly B: Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III: Leucocyte activation: A new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 101:e51–e55. 2006. View Article : Google Scholar : PubMed/NCBI
4	Anitua E, Aguirre JJ, Algorta J, Ayerdi E, Cabezas AI, Orive G and Andia I: Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater. 84:415–421. 2008. View Article : Google Scholar : PubMed/NCBI
5	Rodella LF, Favero G, Boninsegna R, Buffoli B, Labanca M, Scarì G, Sacco L, Batani T and Rezzani R: Growth factors, CD34 positive cells, and fibrin network analysis in concentrated growth factors fraction. Microsc Res Tech. 74:772–777. 2011. View Article : Google Scholar : PubMed/NCBI
6	Kawase T and Tanaka T: An updated proposal for terminology and classification of platelet-rich fibrin. Regen Ther. 7:80–81. 2017. View Article : Google Scholar : PubMed/NCBI
7	Sohn DS, Moon JW, Moon YS, Park JS and Jung HS: The use of concentrated growth factor (CGF) for sinus augmentation. J Oral Implant. 38:25–38. 2009.
8	Sohn DS, Heo JU, Kwak DH, Kim DE, Kim JM, Moon JW, Lee JH and Park IS: Bone regeneration in the maxillary sinus using an autologous fibrin-rich block with concentrated growth factors alone. Implant Dent. 20:389–395. 2011.PubMed/NCBI
9	Yu B and Wang Z: Effect of concentrated growth factors on beagle periodontal ligament stem cells in vitro. Mol Med Rep. 9:235–242. 2014. View Article : Google Scholar : PubMed/NCBI
10	He L, Lin Y, Hu X, Zhang Y and Wu H: A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 108:707–713. 2009. View Article : Google Scholar : PubMed/NCBI
11	Bhattarai N, Gunn J and Zhang M: Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev. 62:83–99. 2010. View Article : Google Scholar : PubMed/NCBI
12	Riva R, Ragelle H, des Rieux A, Duhem N, Jérôme C and Préat V: Chitosan and chitosan derivatives in drug delivery and tissue engineering. Adv Polym Sci. 244:19–44. 2011. View Article : Google Scholar
13	Sonia TA and Sharma CP: Chitosan and its derivatives for drug delivery perspective. Adv Polym Sci. 243:23–53. 2011. View Article : Google Scholar
14	Mengatto LN, Helbling IM and Luna JA: Recent advances in chitosan films for controlled release of drugs. Recent Pat Drug Deliv Formul. 6:156–170. 2012. View Article : Google Scholar : PubMed/NCBI
15	Kumar AS and Ramaswamy NM: Chitosan microspheres as potential vaccine delivery systems. Int J Drug Deliv. 3:43–50. 2011. View Article : Google Scholar
16	Taşkın AK, Yaşar M, Ozaydın I, Kaya B, Bat O, Ankaralı S, Yıldırım U and Aydın M: The hemostatic effect of calcium alginate in experimental splenic injury model. Ulusal Travma Acil Cerrahi Derg. 19:195–199. 2013. View Article : Google Scholar
17	Pinkas O and Zilberman M: Effect of hemostatic agents on properties of gelatin-alginate soft tissue adhesives. J Biomater Sci Polym Ed. 25:555–573. 2014. View Article : Google Scholar : PubMed/NCBI
18	He Q, Gong K, Ao Q, Ma T, Yan Y, Gong Y and Zhang X: Positive charge of chitosan retards blood coagulation on chitosan films. J Biomater Appl. 27:1032–1045. 2013. View Article : Google Scholar : PubMed/NCBI
19	Lam PL, Lee KK, Wong RS, Cheng GY, Cheng SY, Yuen MC, Lam KH, Gambari R, Kok SH and Chui CH: Development of hydrocortisone succinic acid/and 5-fluorouracil/chitosan microcapsules for oral and topical drug deliveries. Bioorg Med Chem Lett. 22:3213–3218. 2012. View Article : Google Scholar : PubMed/NCBI
20	Prins HJ, Braat AK, Gawlitta D, Dhert WJ, Egan DA, Tijssen-Slump E, Yuan H, Coffer PJ, Rozemuller H and Martens AC: In vitro induction of alkaline phosphatase levels predicts in vivo bone forming capacity of human bone marrow stromal cells. Stem Cell Res. 12:428–440. 2014. View Article : Google Scholar : PubMed/NCBI
21	Casati MZ, de Vasconcelos Gurgel BC, Gonçalves PF, Pimentel SP, da Rocha Nogueira Filho G, Nociti FH Jr and Sallum EA: Platelet-rich plasma does not improve bone regeneration around peri-implant bone defects - a pilot study in dogs. Int J Oral Maxillofac Surg. 36:132–136. 2007. View Article : Google Scholar : PubMed/NCBI
22	Schaaf H, Streckbein P, Lendeckel S, Heidinger KS, Rehmann P, Boedeker RH and Howaldt HP: Sinus lift augmentation using autogenous bone grafts and platelet-rich plasma: Radiographic results. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 106:673–678. 2008. View Article : Google Scholar : PubMed/NCBI
23	Dohan Ehrenfest DM, de Peppo GM, Doglioli P and Sammartino G: Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): A gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors. 27:63–69. 2009. View Article : Google Scholar : PubMed/NCBI
24	Marx RE: Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dent. 10:225–228. 2001. View Article : Google Scholar : PubMed/NCBI
25	Park HC, Kim SG, Oh JS, You JS, Kim JS, Lim SC, Jeong MA, Kim JS, Jung C, Kwon YS and Ji H: Early bone formation at a femur defect using CGF and PRF grafts in adult dogs: A comparative study. Implant Dent. 25:387–393. 2016. View Article : Google Scholar : PubMed/NCBI
26	Lu Z and Kipnis J: Thrombospondin 1-a key astrocyte-derived neurogenic factor. FASEB J. 24:1925–1934. 2010. View Article : Google Scholar : PubMed/NCBI
27	Zhao C, Isenberg JS and Popel AS: Human expression patterns: Qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions. J Cell Mol Med. 22:2086–2097. 2018. View Article : Google Scholar : PubMed/NCBI
28	Murphy-Ullrich JE and Suto MJ: Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease. Matrix Biol. 68-69:28–43. 2018. View Article : Google Scholar : PubMed/NCBI
29	Ghadami M, Makita Y, Yoshida K, Nishimura G, Fukushima Y, Wakui K, Ikegawa S, Yamada K, Kondo S, Niikawa N and Tomita Ha: Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3. Am J Hum Genet. 66:143–147. 2000. View Article : Google Scholar : PubMed/NCBI
30	Le Bousse-Kerdilès MC and Martyré MC: Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Ann Hematol. 78:437–444. 1999. View Article : Google Scholar : PubMed/NCBI
31	Wang CY, Li XD, Hao ZH and Xu D: Insulin-like growth factor-1 improves diabetic cardiomyopathy through antioxidative and anti-inflammatory processes along with modulation of Akt/GSK-3β signaling in rats. Korean J Physiol Pharmacol. 20:613–619. 2016. View Article : Google Scholar : PubMed/NCBI
32	Pierce GF, Tarpley JE, Yanagihara D, Mustoe TA, Fox GM and Thomason A: Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol. 140:1375–1388. 1992.PubMed/NCBI
33	Hu K and Olsen BR: The roles of vascular endothelial growth factor in bone repair and regeneration. Bone. 91:30–38. 2016. View Article : Google Scholar : PubMed/NCBI
34	Liu Y, Chen L, Zhou C, Yang J, Hou Y and Wang W: Development and evaluation of alginate-chitosan gastric floating beads loading with oxymatrine solid dispersion. Drug Dev Ind Pharm. 42:456–463. 2016. View Article : Google Scholar : PubMed/NCBI
35	He M, Zhang X, Yao W, Wang C, Shi L and Zhou P: Construction of alternate layered chitosan/alginate composite hydrogels and their properties. Mater Lett. 200:43–46. 2017. View Article : Google Scholar
36	Coppi G and Iannuccelli V: Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system. Int J Pharm. 367:127–132. 2009. View Article : Google Scholar : PubMed/NCBI